Clinicopathological features of patients with biochemical recurrence after radical prostatectomy without progressive rise in serum prostate-specific antigen

Urologia Internationalis

Volumn 77, Issue 3, 2006, Pages 200-204

  Miyake, Hideaki ^a   Hara, Isao ^b   Kurahashi, Toshifumi ^b   Muramaki, Mototsugu ^b   Yamanaka, Kazuki ^b   Inoue, Taka Aki ^a   Fujisawa, Masato ^b  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Biochemical recurrence; Prostate cancer; Prostate specific antigen; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL FEATURE; DIAGNOSTIC KIT; FOLLOW UP; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

AGED; BIOPSY, NEEDLE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33749993419     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094809     Document Type: Article

References (18)

1. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28:555-565.
2. Catalona WJ, Smith DS: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 1998;160:2428-2434.
3. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591-1597.
4. Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H: Defining prostate-specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 2001;165:1146-1151.
5. Haese A, Huland E, Graefen M, Hammerer P, Noldus J, Huland H: Ultrasensitive detection of prostate specific antigen in the follow-up of 422 patients after radical prostatectomy. J Urol 1999;161:1206-1211.
6. Doherty AP, Bower M, Smith GL, Miano R, Mannion EM, Mitchell H, Christmas TJ: Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer 2000;83:1432-1436.
7. Yu H, Diamandis EP, Wong PY, Nam R, Trachtenberg J: Detection of prostate cancer relapse with prostate-specific antigen monitoring at levels of 0.001-0.1 μg/l. J Urol 1997;157:913-918.
8. Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG: Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay. Urology 1997;50:573-579.
9. Witherspoon LR, Lapeyrolerie T: Sensitive prostate-specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol 1997;157:1322-1328.
10. Shinghal R, Yemoto C, McNeal JE, Brooks JD: Biochemical recurrence without PSA progression characterizes a subset of patients after radical prostatectomy. Urology 2003;61:380-385.
11. International Union Against Cancer: TNM Classification of Malignant Tumors. New York, Wiley, 1997, pp 170-173.
12. Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Chang SS, Cookson MS: Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 2002;167:2032-2035.
13. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP: Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993;71:933-938.
14. Freedman SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW: Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005;294:433-439.
15. Shah O, Melamed J, Lepor H: Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol 2001;165:1943-1948.
16. Ponthieu A, Delgrande J, Ivaldi A: Preoperative biopsy of the subapical urethra during prostatectomy for cancer. Prog Urol 1996;6: 250-255.
17. Lepor H, Chan S, Melamed J: The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of bladder neck. J Urol 1998;160:2435-2439.
18. Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, Yemoto C, Stamey TA: The periurethral glands do not significantly influence prostate-specific antigen concentration. J Urol 1996;155:1658-1660.